Living up to this law of nature, the tiny country of Estonia continues to punch above its weight. The country’s uniquely entrepreneurial environment, solid scientific and research foundation, and strongly interconnected scientific community provide the perfect backdrop for breakthroughs ranging from Europe’s first CE-marked cancer polygenic risk score tests to viral transport solution technology that enables direct real-time PCR without the need of any nucleic acid extraction or purification methods.
Meet the leading-edge biotech companies participating at BIO International Convention 2022 and pushing boundaries with their in-depth knowledge and constant drive to improve the world through science.
Connected Health, founded by the Science Park Tehnopol, is a country-wide partnership between health-related stakeholders in Estonia, who are committed to accelerating the adoption of connected health solutions, on an international scale and on commercial terms.
The cluster brings together 80+ partners, including 43 companies (start-ups, health IT, medtech, biotech, and pharma), R&D partners (universities and technology competence centres), health and wellness service providers (hospitals, GPs, occupational health, spas, fitness and sports), patient organisations and user communities, and public sector (ministries responsible for healthcare and entrepreneurship, national health insurance, and the national health development agency).
TFTAK is your ideal microbial consortia contract manufacturing partner. Our full pipeline from genome to bioprocess includes unique species interaction modelling, isothermal microcalorimetry and serial batch-based media screening and robust consortia manufacturing process development with viable cell quantification. We have excellent analytical methods that support the process development. TFTAK is a trusted partner of world-leading companies in the field.
We develop therapeutic and diagnostic antibodies. We also collaborate with other biopharmaceutical, biotechnology and diagnostic companies to accelerate their antibody development, including its manufacturing and stable CHO cell line development. In addition to services, we have several therapeutic antibodies in our pipeline, and a comprehensive selection of off-the-shelf diagnostic reagents. We are known as responsive, scientifically knowledgeable and technically savvy. Our credo is quality.
Solis BioDyne is a global biotech company from Estonia and is a world leader in the development of accurate room temperature stable reagents and enzymes. Over 26 years of experience in Industrial-scale protein design and production gives flexibility and time-to-market leverage to develop a customized product and solution from technical support to assay optimization. High standards have made Solis BioDyne a trusted trademark worldwide, providing solutions to over 110 countries.
IKO Science has invented unique IKO Biodetector BD500 that provides all the functions and technologies necessary for the efficient and accurate measurement/detection, in real time, of viruses and other organic aerosols, such as airborne bacteria, spores etc. inside objects where the concentration of bio-aerosols is strictly limited.
+372 555 firstname.lastname@example.org
Bioatlas has been focusing on PCR and agarose gel electrophoresis for 15 years already. Still, our main aim is to revolutionize agarose gel preparation around the world with the help of our partners. We are looking for distribution partners, OEM resellers and scientific partners to meet our goals. Currently our main goal is to introduce safe DNA stains to every lab around the world. Our patented tablet format makes it even more appealing.
Company founded in 2006 by private capital and contributing to modern healthcare and Biotech Industry. TBD develops, manufactures and sells active pharmaceutical ingredients (API).
We provide our clients with the full spectra of Chemistry-related services necessary for production/registration of API.
We are focused on low volume/high added value products, which means that we can work with both – niche generics and innovative NCEs.
Head of Sales Department
+372 372 74 72 email@example.com
13 Jun 2022
San Diego, USA